Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) Financials

CRBD

Trailing 12 months to June 30, 2026

Revenue $20.1B +29.8% YoY

Net Income $907.0M +369.1% YoY

EPS (Diluted) $1.59 +301.3% YoY

Operating Cash Flow $1.9B +10.4% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRBD SEC filings page.

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) reported $20.1B in revenue over the twelve months to Jun 30, 2026, up 29.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRBD FY2025 2026-08-29

Asset-heavy, liability-funded operations turn recurring operating cash into a business dependent on financing for large investment outflows.

Earnings quality diverged from cash generation: from FY2024 to FY2025, net income fell from $2.2B to -$366M, while operating cash flow remained positive in FY2025. That gap points to non-cash or timing effects influencing reported profitability; unreported free cash flow prevents judging how much operating cash remained after reinvestment.

The balance sheet is thinly capitalized relative to its asset base: FY2025 liabilities were $399.6B against $413.5B of assets. Equity was only $13.2B, alongside a debt-to-equity ratio of 30.3x, so modest changes in asset values could materially affect the equity cushion.

Investment outflows reached $13.3B in FY2025 while financing provided $10.9B, showing that operating cash did not fund the full cash invested. The company also repurchased $2.1B of shares while revenue slipped 1.2% from FY2024, separating shareholder distributions from underlying top-line momentum.

Financial Health Signals

Financial health score not available

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/6

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 reported a net loss of $366.0M while generating $2.0B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.9B

YoY+43.6%

QoQ-1.3%

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 generated $3.9B in revenue in Q2 2026. This represents an increase of 43.6% from the same quarter a year earlier. Against the prior quarter it is down 1.3%.

Net Income

$2.0M

YoY+100.3%

QoQ+103.8%

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 reported $2.0M in net income in Q2 2026. This represents an increase of 100.3% from the same quarter a year earlier. Against the prior quarter it is up 103.8%.

EPS (Diluted)

-$0.04

YoY+96.7%

QoQ+63.6%

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 earned -$0.04 per diluted share (EPS) in Q2 2026. This represents an increase of 96.7% from the same quarter a year earlier. Against the prior quarter it is up 63.6%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$358.0M

YoY+20.9%

QoQ-5.3%

5Y CAGR-17.2%

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 held $358.0M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.25

YoY+4.2%

QoQ0.0%

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 paid $0.25 per share in dividends in Q2 2026. This represents an increase of 4.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

446M

YoY-17.2%

QoQ-2.4%

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 had 446M shares outstanding in Q2 2026. This represents a decrease of 17.2% from the same quarter a year earlier. Against the prior quarter it is down 2.4%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Net Margin

0.1%

YoY+24.3pp

QoQ+1.4pp

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's net profit margin was 0.1% in Q2 2026, showing the share of revenue converted to profit. This is up 24.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Return on Equity

0.0%

YoY+5.4pp

QoQ+0.5pp

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's ROE was 0.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 5.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$300.0M

YoY-3.5%

QoQ-76.0%

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 spent $300.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 3.5% from the same quarter a year earlier. Against the prior quarter it is down 76.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

CRBD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRBD quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Revenue	$20.1B	$18.5B-1.2%	$18.7B-0.5%	$18.8B-23.9%	$24.7B+6.2%	$23.3B+54.4%	$15.1B
SG&A Expenses	$1.9B	$2.0B-0.7%	$2.0B-11.7%	$2.3B-1.8%	$2.3B+10.4%	$2.1B+3.8%	$2.0B
Interest Expense	$529.0M	$552.0M-0.4%	$554.0M-4.5%	$580.0M+8.6%	$534.0M+37.3%	$389.0M-20.6%	$490.0M
Income Tax	$202.0M	-$151.0M-125.2%	$600.0M+725.0%	-$96.0M-104.8%	$2.0B-3.4%	$2.1B+13980.0%	-$15.0M
Net Income	$907.0M	-$366.0M-116.4%	$2.2B+102.0%	$1.1B-86.5%	$8.2B-1.0%	$8.2B+1184.0%	$642.0M
EPS (Basic)	N/A	-$0.68-118.2%	$3.73+116.9%	$1.72-86.4%	$12.63	N/A	N/A
EPS (Diluted)	$1.59	-$0.68-118.3%	$3.72+117.5%	$1.71-86.4%	$12.60	N/A	N/A
Diluted Shares (Avg)	N/A	539M-10.0%	599M-7.1%	645M-0.3%	647M	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$3.9B+43.6%	$4.0B+11.0%	$6.8B+3.1%	$5.4B+108.4%	$2.7B-26.5%	$3.6B-38.8%	$6.6B+100.3%	$2.6B-52.8%
SG&A Expenses	$466.0M-9.9%	$468.0M-11.0%	$478.0M+9.4%	$481.0M+1.3%	$517.0M-2.8%	$526.0M-8.0%	$437.0M-9.9%	$475.0M-22.3%
Interest Expense	$131.0M-4.4%	$131.0M-11.5%	$132.0M-9.0%	$135.0M+1.5%	$137.0M-0.7%	$148.0M+7.2%	$145.0M+4.3%	$133.0M-1.5%
Income Tax	$50.0M-16.7%	$158.0M+177.1%	$173.0M-75.4%	-$179.0M+56.0%	$60.0M-47.8%	-$205.0M-208.5%	$703.0M+262.7%	-$407.0M-203.8%
Net Income	$2.0M+100.3%	-$53.0M+92.0%	$814.0M-62.5%	$144.0M+112.2%	-$660.0M-280.8%	-$664.0M-175.6%	$2.2B+265.9%	-$1.2B-156.4%
EPS (Basic)	-$0.04+96.7%	-$0.11+90.8%	$1.47-59.5%	$0.27+113.4%	-$1.20-300.0%	-$1.19-184.4%	$3.63+280.6%	-$2.02-161.4%
EPS (Diluted)	-$0.04+96.7%	-$0.11+90.8%	$1.47-59.4%	$0.27+113.4%	-$1.20-303.4%	-$1.19-184.4%	$3.62+280.1%	-$2.02-161.6%
Diluted Shares (Avg)	454M-17.5%	474M-15.1%	N/A	541M-7.9%	550M-10.2%	558M-10.7%	N/A	587M-8.4%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

CRBD Balance Sheet

CRBD quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	$413.5B+6.2%	$389.4B+2.7%	$379.3B+5.3%	$360.3B-15.3%	$425.4B+0.7%	$422.4B
Cash & Equivalents	$453.0M-45.0%	$824.0M+31.2%	$628.0M-0.8%	$633.0M+5.3%	$601.0M-34.5%	$918.0M
Short-Term Investments	$5.7B+13.9%	$5.0B+14.9%	$4.3B-1.5%	$4.4B-19.6%	$5.5B	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	$117.0M-33.1%	$175.0M-8.9%	$192.0M-11.9%	$218.0M
Total Liabilities	$399.6B+6.0%	$377.1B+2.8%	$366.6B+4.8%	$350.0B-11.7%	$396.4B+3.3%	$383.8B
Long-Term Debt	N/A	N/A	N/A	$7.9B+1742.6%	$427.0M	N/A
Total Equity	$13.2B+15.2%	$11.5B-2.6%	$11.8B+25.4%	$9.4B-65.6%	$27.2B-24.5%	$36.1B
Retained Earnings	$18.4B-4.6%	$19.3B+9.6%	$17.6B-3.5%	$18.2B+66.5%	$10.9B-54.0%	$23.8B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$415.8B+4.2%	$407.1B+4.4%	$413.5B+6.2%	$411.3B+3.0%	$399.2B+4.4%	$390.0B+1.1%	$389.4B+2.7%	$399.4B+12.3%
Cash & Equivalents	$358.0M+20.9%	$378.0M-5.3%	$453.0M-45.0%	$322.0M-41.1%	$296.0M-54.7%	$399.0M-6.3%	$824.0M+31.2%	$547.0M-5.9%
Short-Term Investments	$4.6B+20.4%	$4.7B-24.1%	$5.7B+13.9%	$4.6B-5.2%	$3.8B-23.7%	$6.2B+50.4%	$5.0B+14.9%	$4.9B+3.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$404.4B+4.8%	$395.5B+4.9%	$399.6B+6.0%	$397.0B+3.1%	$386.0B+4.1%	$377.2B+1.1%	$377.1B+2.8%	$385.0B+11.2%
Total Equity	$10.7B-13.4%	$10.8B-9.8%	$13.2B+15.2%	$13.5B-0.5%	$12.3B+11.9%	$12.0B+3.5%	$11.5B-2.6%	$13.6B+62.7%
Retained Earnings	$18.1B+2.3%	$18.2B-1.4%	$18.4B-4.6%	$17.7B+2.7%	$17.7B-4.7%	$18.5B+0.8%	$19.3B+9.6%	$17.2B-12.9%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

CRBD Cash Flow Statement

CRBD quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	$1.9B	$2.0B-6.0%	$2.2B-35.9%	$3.4B+28.1%	$2.6B+9.0%	$2.4B-27.7%	$3.3B
Depreciation & Amortization	N/A	$556.0M+188.1%	$193.0M-47.3%	$366.0M-37.4%	$585.0M+41.6%	$413.0M+27.1%	$325.0M
Stock-Based Compensation	N/A	$67.0M+15.5%	$58.0M-3.3%	$60.0M-20.0%	$75.0M-14.8%	$88.0M+18.9%	$74.0M
Investing Cash Flow	-$7.8B	-$13.3B-15.6%	-$11.5B-110.7%	-$5.5B+24.5%	-$7.3B-268.7%	-$2.0B+75.1%	-$7.9B
Financing Cash Flow	$6.0B	$10.9B+14.2%	$9.6B+353.2%	$2.1B-54.8%	$4.7B+720.7%	-$753.0M-116.1%	$4.7B
Dividends Paid	$473.0M	$511.0M-6.1%	$544.0M-68.4%	$1.7B+96.6%	$876.0M	$0	$0
Share Buybacks	$3.0B	$2.1B+18.2%	$1.8B+259.8%	$498.0M	$0	$0	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$44.0M+83.0%	-$9.0M-102.4%	$1.9B+27.2%	$24.0M-71.1%	-$259.0M-2777.8%	$375.0M-37.3%	$1.5B+92.8%	$83.0M-91.8%
Depreciation & Amortization	$173.0M+84.0%	$165.0M+85.4%	$174.0M+185.2%	$199.0M+452.8%	$94.0M+193.8%	$89.0M+39.1%	$61.0M+205.0%	$36.0M-66.4%
Investing Cash Flow	$1.6B+158.6%	-$2.5B+34.6%	-$3.5B-157.2%	-$3.3B+46.7%	-$2.7B-102.6%	-$3.9B-46.4%	-$1.3B+38.9%	-$6.2B-161.8%
Financing Cash Flow	-$1.5B-154.5%	$2.5B-19.7%	$1.7B+1078.1%	$3.3B-45.0%	$2.8B+81.7%	$3.1B+66.7%	$146.0M-90.0%	$6.0B+407.1%
Dividends Paid	$112.0M-14.5%	$114.0M-14.3%	$119.0M-7.8%	$128.0M-3.8%	$131.0M-5.8%	$133.0M-7.0%	$129.0M-85.3%	$133.0M-8.9%
Share Buybacks	$300.0M-3.5%	$1.3B+289.4%	$1.1B+177.9%	$380.0M-46.9%	$311.0M-28.7%	$321.0M+32.1%	$398.0M+57.9%	$715.0M+1454.3%

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow.

CRBD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRBD quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Net Margin	-2.0%-13.9pp	11.9%+6.0pp	5.9%-27.2pp	33.0%-2.4pp	35.4%+31.2pp	4.3%
Return on Equity	-2.8%-22.2pp	19.5%+10.1pp	9.4%-77.6pp	87.0%+56.7pp	30.3%+28.5pp	1.8%
Return on Assets	-0.1%-0.7pp	0.6%+0.3pp	0.3%-2.0pp	2.3%+0.3pp	1.9%+1.8pp	0.1%
Debt-to-Equity	30.27-2.6x	32.90+1.7x	31.16+30.3x	0.84+0.8x	0.02-10.6x	10.64
Asset Turnover	0.040.0x	0.050.0x	0.050.0x	0.070.0x	0.050.0x	0.04

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	0.1%+24.3pp	-1.3%+17.3pp	12.0%-21.0pp	2.7%+48.2pp	-24.2%-34.1pp	-18.6%-33.6pp	33.1%+73.0pp	-45.6%-83.7pp
Return on Equity	0.0%+5.4pp	-0.5%+5.0pp	6.2%-12.8pp	1.1%+9.8pp	-5.4%-8.7pp	-5.5%-13.1pp	18.9%+30.1pp	-8.7%-33.8pp
Return on Assets	0.0%+0.2pp	0.0%+0.2pp	0.2%-0.4pp	0.0%+0.3pp	-0.2%-0.3pp	-0.2%-0.4pp	0.6%+0.9pp	-0.3%-0.9pp
Debt-to-Equity	37.97+6.6x	36.61+5.1x	30.27-2.6x	29.31+1.0x	31.38-2.3x	31.48-0.8x	32.90+1.7x	28.29-13.1x
Asset Turnover	0.010.0x	0.010.0x	0.020.0x	0.010.0x	0.010.0x	0.010.0x	0.020.0x	0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Where Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 Ranks

Frequently Asked Questions

What is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's annual revenue?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) reported $18.5B in total revenue for fiscal year 2025. This represents a -1.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's revenue growing?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) revenue declined by 1.2% year-over-year, from $18.7B to $18.5B in fiscal year 2025.

Is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 profitable?

No, Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) reported a net income of -$366.0M in fiscal year 2025, with a net profit margin of -2.0%.

What is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's earnings per share (EPS)?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) reported diluted earnings per share of -$0.68 for fiscal year 2025. This represents a -118.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's net profit margin?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) had a net profit margin of -2.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's return on equity (ROE)?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) has a return on equity of -2.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's operating cash flow?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) generated $2.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's total assets?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) had $413.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 buy back shares?

Yes, Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) spent $2.1B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 have outstanding?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) had 482M shares outstanding as of fiscal year 2025.

What is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's debt-to-equity ratio?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) had a debt-to-equity ratio of 30.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's return on assets (ROA)?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) had a return on assets of -0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's Piotroski F-Score?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064's earnings high quality?

Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) reported a net loss of $366.0M while generating $2.0B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.